News

Emami trades higher on subscribing additional stake in Brillare Science Emami is currently trading at Rs. 517.50, up by 3.75 points or 0.73% from its previous closing of Rs. 513.75 on the BSE. The scrip opened at Rs. 504.35 and has touched a high and low of Rs. 521.00 and Rs. 504.35 respectively. So far 11176 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.95 on 26-Sep-2022 and a 52 week low of Rs. 340.95 on 20-Mar-2023. Last one week high and low of the scrip stood at Rs. 521.0...
Emami trades higher on subscribing additional stake in Brillare Science
Emami trades higher on subscribing additional stake in Brillare Science
Source: Accord Fintech
11/08/2023 12:30:55 PM
Buy Emami Ltd For Target Rs. 590- Centrum Broking Ltd Emami’s Q1FY24 print was mixed to our estimates; consolidated revenue/EBITDA/APAT grew 6.8%/ 9.6%/23.4% YoY. Domestic value/volume grew at 7.0%/3.0%, yet international business saw 8.0% growth (~11% CC). Management alluded slower growth to, (1) despite early summer, unseasonal rains in May cut sales of summer products - declined 5%, (2) domestic non-summer portfolio grew 16%, (3) softer demand in rural impacted value-add hair oils, and (4) robust growth in MT/e-com channel at 45%/47% (1...
Buy Emami Ltd For Target Rs. 590- Centrum Broking Ltd
Buy Emami Ltd For Target Rs. 590- Centrum Broking Ltd
Source: Centrum Broking Ltd
10/08/2023 4:09:11 PM
Emami surges on reporting 88% rise in Q1 consolidated net profi Emami is currently trading at Rs. 469.80, up by 8.05 points or 1.74% from its previous closing of Rs. 461.75 on the BSE. The scrip opened at Rs. 463.75 and has touched a high and low of Rs. 471.90 and Rs. 463.10 respectively. So far 38760 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.95 on 26-Sep-2022 and a 52 week low of Rs. 340.95 on 20-Mar-2023. Last one week high and low of the scrip stood at Rs. 471.9...
Emami surges on reporting 88% rise in Q1 consolidated net profi
Emami surges on reporting 88% rise in Q1 consolidated net profi
Source: Accord Fintech
8/08/2023 12:15:24 PM
Emami zooms on investing Rs 4.50 crore in Cannis Emami is currently trading at Rs. 398.75, up by 17.50 points or 4.59% from its previous closing of Rs. 381.25 on the BSE. The scrip opened at Rs. 386.95 and has touched a high and low of Rs. 403.00 and Rs. 384.05 respectively. So far 16088 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.95 on 26-Sep-2022 and a 52 week low of Rs. 340.95 on 20-Mar-2023. Last one week high and low of the scrip stood at Rs. 403....
Emami zooms on investing Rs 4.50 crore in Cannis
Emami zooms on investing Rs 4.50 crore in Cannis
Source: Accord Fintech
16/06/2023 3:31:33 PM
Buy Emami Ltd For Target Rs.460 - Motilal Oswal Financial Services Ltd Margin outlook improving; rural recovery essential * HMN reported better-than-expected sales in 4QFY23 (up 8.8% YoY). The overall domestic volumes grew ~2%, while organic business volumes continued to decline, affected by persistent weakness in rural and summer portfolio due to excessive unseasonal rainfall in some parts of the country. * The management has guided for a ~200-250bp expansion in gross margin going ahead and expects A&P spends to be ~17% of sales. It is also encouragin...
Buy Emami Ltd For Target Rs.460 - Motilal Oswal Financial Services Ltd
Buy Emami Ltd For Target Rs.460 - Motilal Oswal Financial Services Ltd
Source: Motilal Oswal Financial Services Ltd
30/05/2023 2:57:29 PM
Buy Emami Ltd For Target Rs.610 - Centrum Broking Emami’s Q3FY23 print was tad above our estimates; revenue grew 1.1%, (3?year CAGR 6.0%). EBITDA and PAT fell by 13.8%/5.3% due to (1) softer demand in rural impacting value? add hair oils, (2) protracted winter disrupted winter?care portfolio, and (3) adjustment in pain management/ healthcare portfolio. India business grew soft at 1.0%, whilst volumes declined 3.0%. International business grew at 7.0% (3?year CAGR 13.0%), yet institutional business grew tepid. MT/E?com channels grew 20....
Buy Emami Ltd For Target Rs.610 - Centrum Broking
Buy Emami Ltd For Target Rs.610 - Centrum Broking
Source: Centrum Broking
28/03/2023 1:55:49 PM
Emami inches up on subscribing additional stake in Brillare Science Emami is currently trading at Rs. 388.45, up by 1.15 points or 0.30% from its previous closing of Rs. 387.30 on the BSE. The scrip opened at Rs. 385.05 and has touched a high and low of Rs. 398.00 and Rs. 385.05 respectively. So far 861 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.95 on 26-Sep-2022 and a 52 week low of Rs. 374.90 on 27-Feb-2023. Last one week high and low of the scrip stood at Rs. 405.90 ...
Emami inches up on subscribing additional stake in Brillare Science
Emami inches up on subscribing additional stake in Brillare Science
Source: Accord Fintech
3/03/2023 10:59:09 AM
Emami soars on reporting 6% rise in Q3 consolidated net profit Emami is currently trading at Rs. 428.05, up by 8.75 points or 2.09% from its previous closing of Rs. 419.30 on the BSE. The scrip opened at Rs. 419.95 and has touched a high and low of Rs. 428.05 and Rs. 416.90 respectively. So far 1442 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.95 on 26-Sep-2022 and a 52 week low of Rs. 393.60 on 20-Jun-2022. Last one week high and low of the scrip stood at Rs. 449.20...
Emami soars on reporting 6% rise in Q3 consolidated net profit
Emami soars on reporting 6% rise in Q3 consolidated net profit
Source: Accord Fintech
6/02/2023 10:20:11 AM
Buy Emami Ltd For Target Rs.550 - Motilal Oswal Financial Services Ltd Operating performance disappoints, margin outlook better for 2HFY23 * HMN reported a weak set of 2QFY23 earnings. Consolidated sales grew 3.2% YoY, despite the consolidation of Helios (which contributed 3.5% to net sales) in 2Q and Dermicool in 1QFY23. Overall volumes fell 1% YoY in 2QFY23 v/s our expectation of 7% growth. HMN’s rural salience (the highest among its peers) is adversely affecting growth. There was also a doubledigit YoY fall in Pain Management/Healthcare/Kesh King sal...
Buy Emami Ltd For Target Rs.550 - Motilal Oswal Financial Services Ltd
Buy Emami Ltd For Target Rs.550 - Motilal Oswal Financial Services Ltd
Source: Motilal Oswal Financial Services Ltd
16/12/2022 12:27:36 PM
Buy Emami Ltd For Target Rs.642 - Centrum Broking Softer demand in rural impacted Q2 revenues Emami’s Q2FY23 print was below our estimates; revenue grew 3.4%, yet EBITDA/ PAT tumbled by 29.5%/3.9% due to (1) softer demand in rural impacting hair oils demand, and (2) correction in pain management and healthcare portfolio. Domestic business grew muted at 1.2%, whilst volumes declined 1.2%. International business saw robust growth of 17.0%, yet institutional business (CSD) grew tepid. MT/ E-com channels grew 28.0%/ 55.0% making up sale...
Buy Emami Ltd For Target Rs.642 - Centrum Broking
Buy Emami Ltd For Target Rs.642 - Centrum Broking
Source: Centrum Broking
8/12/2022 2:13:31 PM
Buy Emami Ltd For Target Rs.657- Centrum Broking Strong recovery in International business Our recent interaction with Emami management reiterated its confidence in driving growth across domestic and international markets. The revived strategy would focus on: (1) expanding rural distribution through Project Khoj (50k villages by Mar’23), (2) Project Serius – efficiency improvement through beat optimization in urban markets, (3) drive healthcare through medico marketing, doctor coverage, NPD, and feet on street, and (4) aim fo...
Buy Emami Ltd For Target Rs.657- Centrum Broking
Buy Emami Ltd For Target Rs.657- Centrum Broking
Source: Centrum Broking Ltd
13/09/2022 9:14:52 AM
Buy Emami Ltd For Target Rs.520 - Motilal Oswal Financial Services Ltd Subdued result trend continues                                                                                                      however, HMN is investing on growth * Emami (HMN)’s overall volume growth in 1QFY23 stood at 9.6% YoY...
Buy Emami Ltd For Target Rs.520 - Motilal Oswal Financial Services Ltd
Buy Emami Ltd For Target Rs.520 - Motilal Oswal Financial Services Ltd
Source: Motilal Oswal Financial Services Ltd
12/09/2022 12:44:53 PM
Buy Emami Ltd For Target Rs.590 - Yes Securities Inferior product mix and higher inflation weigh on margins; maintain BUY Our view Emami posted a better than expected revenue growth at 17.8% with 9.6% volume growth. Volume growth stood at 2.6% excl. Dermicool on a high base.    Pain management and Healthcare declined from a high base while Navratna and Keshking performed well. Strong focus on MT and e?commerce channels seems to be helping the company in driving penetration of its core brands. Gross margins came off only shar...
Buy Emami Ltd For Target Rs.590 - Yes Securities
Buy Emami Ltd For Target Rs.590 - Yes Securities
Source: Yes Securities Ltd
23/08/2022 2:15:34 PM
Buy Emami Ltd For Target Rs.540 - Religare Broking * Emami traded largely in sync with other FMCG counters during the recovery phase post the covid crash. It jumped from the lows of 126 and retested the record high zone around 610 in just one and a half years. * It witnessed a year-long corrective phase after the phenomenal surge and retested the support zone around 400 levels. The last three months of the move indicate strong base formation. * It has recently crossed the trendline hurdle and also surpassed the previous swing high with ...
Buy Emami Ltd For Target Rs.540 - Religare Broking
Buy Emami Ltd For Target Rs.540 - Religare Broking
Source: Religare Broking Ltd
23/08/2022 10:45:55 AM
Weekly Tech Picks - Astra Microwave Products Ltd, Emami Ltd, Thermax Ltd, Sun Pharma Advanced Research Company Ltd By Axis Securities Astra Microwave Products Limited • On the weekly time frame the stock has decisively broken out one year “consolidation zone” breakout at 292 levels on a closing basis . This breakout is accompanied with huge volumes indicating increased participation • The stock is well placed above 20, 50, 100 and 200 day SMA’s which reconfirms bullish trend Astra Microwave Products Limited Weekly Tech Picks 19 August,2022reconfirms bullish trend • On the daily and ...
Weekly Tech Picks - Astra Microwave Products Ltd, Emami Ltd, Thermax Ltd, Sun Pharma Advanced Research Company Ltd By Axis Securities
Weekly Tech Picks - Astra Microwave Products Ltd, Emami Ltd, Thermax Ltd, Sun Pharma Advanced Research Company Ltd By Axis Securities
Source: Axis Securities Ltd
22/08/2022 12:31:24 PM
Emami acquires 30% stake in `Cannis Lupus Services India` Emami has acquired 30% stake in a pet-care start-up ‘Cannis Lupus Services India’. With increasing awareness of the overall health benefits that natural products offer, consumers are more inclined towards use of such natural and ayurvedic products. Chemical free products which are good for humans are also good for pets. This preference for 'wellness products' gets naturally extended to the house pets who are an integral part of a family. The extensive knowledge and expe...
Emami acquires 30% stake in `Cannis Lupus Services India`
Emami acquires 30% stake in `Cannis Lupus Services India`
Source: Accord Fintech
22/07/2022 9:26:31 AM
Emami trades higher on the BSE Emami is currently trading at Rs. 437.80, up by 2.80 points or 0.64% from its previous closing of Rs. 435.00 on the BSE. The scrip opened at Rs. 439.60 and has touched a high and low of Rs. 440.00 and Rs. 423.80 respectively. So far 7367 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 621.35 on 24-Aug-2021 and a 52 week low of Rs. 393.60 on 20-Jun-2022. Last one week high and low of the scrip stood at Rs. 436.55...
Emami trades higher on the BSE
Emami trades higher on the BSE
Source: Accord Fintech
5/07/2022 3:26:11 PM
Buy Emami Ltd For Target Rs.590 - Yes Securities Growth comes off from high base, aggressive marketing spends despite margin pressure a positive; maintain BUY Our view Emami posted a resilient quarter with flattish volume and 5% revenue growth despite the high base, weak consumer sentiment and inflationary headwinds, with steady market shares and strong distribution‐led growth in rural markets. Strong focus on MT and e‐ commerce channels seems to be helping the company in driving penetration of its core brands. Margins came off only m...
Buy Emami Ltd For Target Rs.590 - Yes Securities
Buy Emami Ltd For Target Rs.590 - Yes Securities
Source: Yes Securities Ltd
16/05/2022 12:59:15 PM
Emami Q4 net profit zooms 299.16% at Rs 364.23 cr The company reported standalone net profit of Rs 364.23 crore for the quarter ended March 31, 2022 as compared to Rs 91.25 crore in the same period last year, registering a year-on-year growth of 299.16 per cent. Net revenue of the company rose marginally by 3.57 per cent at Rs 671.59 crore in January-March quarter of this fiscal as against Rs 648.46 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 5.65 per cent to Rs 523.58 crore f...
Emami Q4 net profit zooms 299.16% at Rs 364.23 cr
Emami Q4 net profit zooms 299.16% at Rs 364.23 cr
Source: Dion Global Solutions Ltd
14/05/2022 12:42:12 PM
Buy Emami Ltd For Target Rs.669 - Centrum Broking Dermicool acquisition braces #1 position in cool talc In line with its strategy - strengthening core brand, Emami announced the acquisition of leading brand ‘Dermicool’ in the Prickly heat and cool talc segment from Reckitt Benckiser for a consideration of Rs4.32bn excluding taxes (total 4.5x sales). Further cool talc market has grown CAGR ~14% over past decade except Covid period. More importantly this strategic acquisition provides: (a) market leadership with combined market ...
Buy Emami Ltd For Target Rs.669 - Centrum Broking
Buy Emami Ltd For Target Rs.669 - Centrum Broking
Source: Centrum Broking Ltd
29/03/2022 12:52:47 PM
Add Emami Ltd For Target Rs.550 - ICICI Securities In-line (quantitative and qualitative) Emami reported a good 3Q with 4% YoY revenue growth (2-year CAGR: +9%) and good EBITDA margin print (35%). Healthcare and Pain Management continued to deliver steady performances. Most of the portfolio, except Male Grooming, largely continues to perform well. Upcoming season for Navratna is key as Emami has faced some disruptions in the previous two seasons. Healthcare continues to see good momentum in existing products as well. We like management eff...
Add Emami Ltd For Target Rs.550 - ICICI Securities
Add Emami Ltd For Target Rs.550 - ICICI Securities
Source: ICICI Securities Ltd
18/03/2022 10:15:31 AM
Buy Emami Ltd For Target Rs.621 - Yes Securities Focused on driving penetration‐led growth with margins well protected, valuations attractive; maintain BUY Our view Emami posted another resilient quarter with flattish volume and 4% revenue growth despite the high base and inflationary headwinds, with steady market shares and strong distribution‐led growth in rural markets. Strong focus on MT and e‐commerce channels seems to be helping the company in driving penetration of its core brands. Margins are also holding up quite despite shar...
Buy Emami Ltd For Target Rs.621 - Yes Securities
Buy Emami Ltd For Target Rs.621 - Yes Securities
Source: Yes Securities Ltd
11/02/2022 8:39:22 AM
Emami founders step down from executive positions Emami Limited, at a board meeting held on Thursday, announced that its founders, R.S. Agarwal and R.S. Goenka have expressed their desire to step down from their current executive positions while continuing on the Board. Accordingly, the Board unanimously decided to appoint R.S. Goenka as Non-Executive Chairman while re-designating R.S. Agarwal as Chairman Emeritus effective 1st April, 2022. Both the Founders will not accept any emoluments from the Company for taking up their new positi...
Emami founders step down from executive positions
Emami founders step down from executive positions
Source: IANS
3/02/2022 3:40:00 PM
Emami gains on introducing German skincare brand Creme 21 to Indian market Emami is currently trading at Rs. 545.00, up by 18.65 points or 3.54% from its previous closing of Rs. 526.35 on the BSE. The scrip opened at Rs. 527.80 and has touched a high and low of Rs. 549.85 and Rs. 527.80 respectively. So far 8889 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 621.35 on 24-Aug-2021 and a 52 week low of Rs. 393.70 on 22-Dec-2020. Last one week high and low of the scrip stood at Rs. 549.8...
Emami gains on introducing German skincare brand Creme 21 to Indian market
Emami gains on introducing German skincare brand Creme 21 to Indian market
Source: Accord Fintech
15/12/2021 12:47:35 PM
Add Emami Ltd For Target Rs.600 - ICICI Securities Continues to execute well Emami reported a good quarter with 9% (2-year CAGR: 11%) domestic revenue growth (6.2% volume growth) and almost flattish EBITDA margin print (notwithstanding GM pressure). Healthcare and Pain Management continued to deliver steady performances lapping high bases (2-year CAGR for both 18-26%). Most of the portfolio, except Navratna and Male Grooming, largely continues to do well. GM outlook seems to be a concern but levers exist for overall margin print. Currently...
Add Emami Ltd For Target Rs.600 - ICICI Securities
Add Emami Ltd For Target Rs.600 - ICICI Securities
Source: ICICI Securities Ltd
6/12/2021 9:10:48 AM
Buy Emami Ltd For Target Rs.691 - Yes Securities Strong underlying demand with solid margin performance; reasonable valuations warrant maintaining BUY Our view Emami posted another quarter of resilient performance on topline and margins front amidst inflationary headwinds, giving a strong outlook for the remainder of the year. Strong focus on MT and e-commerce channels seems to be helping the company in driving penetration of its core brands. Margins are also holding up quite well given the 3.5% price hike and continued cost efficienc...
Buy Emami Ltd For Target Rs.691 - Yes Securities
Buy Emami Ltd For Target Rs.691 - Yes Securities
Source: Yes Securities Ltd
1/11/2021 11:24:26 AM
Key News - Reliance Retail Ventures Ltd, Oberoi Realty Ltd, IndiGo Ltd, National Company Law Appellate Tribunal, Piramal Enterprises Ltd, Emami Ltd By ARETE Securities Key News Reliance Retail Ventures brings 7-Eleven to India after Future exit Reliance Retail Ventures (RRVL), the country’s largest retailer with over 12,800 active stores, is all set to enter the fast-growing convenience store segment after it struck a crucial franchisee deal with American major 7- Eleven, Inc (SEI). Days after 7-Eleven’s franchise deal with Future Retail (FRL) fell through, RRVL grabbed the master franchisee for the Dallas-based convenience brand for the I...
Key News - Reliance Retail Ventures Ltd, Oberoi Realty Ltd, IndiGo Ltd, National Company Law Appellate Tribunal, Piramal Enterprises Ltd, Emami Ltd By ARETE Securities
Key News - Reliance Retail Ventures Ltd, Oberoi Realty Ltd, IndiGo Ltd, National Company Law Appellate Tribunal, Piramal Enterprises Ltd, Emami Ltd By ARETE Securities
Source: ARETE Securities Ltd
8/10/2021 9:09:55 AM
Key News - Vodafone Idea Ltd, National Company Law Tribunal, Persistent Systems Ltd, Emami Ltd, Max Healthcare Institute Ltd By ARETE Securities Key News Vodafone Idea reworking business plans after govt reforms' boost Vodafone Idea (Vi) is working on a fresh business plan that could alter its funding requirements. Addressing shareholder queries at the company's annual general meeting (AGM) on Wednesday, Vi Chairman Himanshu Kapania said the exact amount will be worked out upon submission of a new business plan. “The management is working on a new business plan and will come to the board with the funding requiremen...
Key News - Vodafone Idea Ltd, National Company Law Tribunal, Persistent Systems Ltd, Emami Ltd, Max Healthcare Institute Ltd By ARETE Securities
Key News - Vodafone Idea Ltd, National Company Law Tribunal, Persistent Systems Ltd, Emami Ltd, Max Healthcare Institute Ltd By ARETE Securities
Source: ARETE Securities Ltd
30/09/2021 9:16:15 AM
Add Emami Ltd For Target Rs.620 - ICICI Securities Steady business momentum led by improved execution Healthcare and Pain Management continued to aid a decent top-line performance (slightly above estimate). There was pressure in Navratna and Male Grooming, dragging the overall revenue growth to just 1% (on a 2-year CAGR basis). Besides the pandemic-led tailwind, healthcare and pain management did benefit from (1) distribution expansion (balms in north and rural markets) (2) new product launches in the healthcare segment (good momentum in e...
Add Emami Ltd For Target Rs.620 - ICICI Securities
Add Emami Ltd For Target Rs.620 - ICICI Securities
Source: ICICI Securities
10/09/2021 11:49:19 AM
Buy Emami Ltd For Target Rs.560 - Motilal Oswal Margin outlook getting better; sales recovery key to re-rating * Emami (HMN)’s 1QFY22 sales were in line with expectations. Domestic sales grew 5% v/s 1QFY20 levels. While Healthcare and Pain Management have nearly doubled over 1QFY20 levels, the impact of the second COVID wave led lockdown resulted in sharp decline over 1QFY20 in Navratna (in the crucial summer season) and Male Grooming. * The outlook for the domestic business gradually improved in Jun’21 and Jul’21,...
Buy Emami Ltd For Target Rs.560 - Motilal Oswal
Buy Emami Ltd For Target Rs.560 - Motilal Oswal
Source: Motilal Oswal Financial Services Ltd
28/08/2021 12:25:55 PM
Buy Emami Limited Target Rs. 630 - Religare Broking Religare Super Idea   To Read Complete Report & Disclaimer Click Here   Please refer disclaimer http://ex.religareonline.com/disclaimer SEBI Registration number is INZ000174330   Above views are of the author and not of the website kindly read disclaimer
Buy Emami Limited Target Rs. 630 - Religare Broking
Buy Emami Limited Target Rs. 630 - Religare Broking
Source: Religare Broking Ltd
18/08/2021 10:48:45 AM
Buy Emami Ltd For Target Rs. 691 - Yes Securities Earnings momentum continues, valuations remain attractive; reiterate BUY Result Highlights * Growth summary – 38% volume and 42% revenue growth in domestic business, domestic growth 5% above 1QFY20 levels; international business still lagging. * Brand‐wise performance  ‐  Compared to 1QFY20, healthcare and pain management up 95%, Boro Plus up 32%, 7 Oils in One up 17%, Kesh King up 2%; decline of 29% in Navratna and 47% in male grooming. * Margins  ‐ GMs down ...
Buy Emami Ltd For Target Rs. 691 - Yes Securities
Buy Emami Ltd For Target Rs. 691 - Yes Securities
Source: Yes Securities
3/08/2021 10:44:05 AM
Quote on Emami -1QFY22 - Result Update by Mr. Amarjeet Maurya, Angel Broking Ltd Below is quote on Emami -1QFY22 - Result Update by Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd During 1QFY22, Emami Ltd (EL) Sales grew ~37% to Rs6.6bn on healthy  growth. Domestic business grew ~42% (volume growth was ~38%), international ~17% and institutional grew ~34%. Gross margin slightly declined by 50bp. EBITDA grew ~38% to Rs1.7bn on back of lower other overhead spends. EBITDA margins at 25.7% growing by 20 bps. The reported...
Quote on Emami -1QFY22 - Result Update by Mr. Amarjeet Maurya, Angel Broking Ltd
Quote on Emami -1QFY22 - Result Update by Mr. Amarjeet Maurya, Angel Broking Ltd
Source: Angel Broking Ltd
2/08/2021 4:14:12 PM
Key News - Emami Ltd , Power Mech Projects Ltd, Oil and Natural Gas Corporation, Dewan Housing Finance Corporation Ltd, SEBI by ARETE Securities Key News Emami ups stake to 46% from 33% in male grooming company Helios Lifestyle FMCG firm Emami Ltd has upped its stake in Helios Lifestyle, known for its male grooming brand, The Man Company (TMC). Emami said on Monday that it had increased its existing strategic stake of 33.09 per cent to 45.96 per cent in Helios Lifestyle (Helios) and with the investment, it had further consolidated its position as the largest shareholder of TMC. Emami’s 33.09 per cent holding in the company...
Key News - Emami Ltd , Power Mech Projects Ltd, Oil and Natural Gas Corporation, Dewan Housing Finance Corporation Ltd, SEBI by ARETE Securities
Key News - Emami Ltd , Power Mech Projects Ltd, Oil and Natural Gas Corporation, Dewan Housing Finance Corporation Ltd, SEBI by ARETE Securities
Source: ARETE Securities Ltd
29/06/2021 9:11:23 AM
Emami raises stake in Helios Lifestyle to 45%  FMCG company Emami Ltd has increased its existing strategic stake of 33.09 per cent to 45.96 per cent in Helios Lifestyle Pvt Ltd. In a regulatory filing, Emami said that the nature of consideration was cash. However, it did not disclose the investment amount due to "reasons of confidentiality". This investment is in line with the company's strategy of leveraging emerging online opportunities brought about by rapid digitisation, said a regulatory filing. With this in...
Emami raises stake in Helios Lifestyle to 45%
Emami raises stake in Helios Lifestyle to 45%
Source: IANS
28/06/2021 2:27:12 PM
Buy Emami Ltd For Target Rs. 550 - ICICI Securities Steady momentum Q4 volumes grew 6% (2-year CAGR) primarily led by healthcare and pain management. Navratna had a decent quarter while Kesh King and BoroPlus were slightly weak; male grooming is the only drag, for now. International business (17% of revenues) is also performing well (+12% in FY21). RM pressure impacted gross margins but price increases are being taken to mitigate the impact. We believe Emami has seen a marked improvement in execution over the last few quarters. While some p...
Buy Emami Ltd For Target Rs. 550 - ICICI Securities
Buy Emami Ltd For Target Rs. 550 - ICICI Securities
Source: ICICI Securities
25/06/2021 11:40:03 AM
Buy Emami Ltd For Target Rs. 580 - Motilal Oswal Sales in line; some margin pressure emerging * HMN’s 4QFY21 sales/volume growth of 37%/39% was broadly in line with our estimate. Albeit, aided by advance summer season sales in 4QFY21, unlike the same quarter last year, two-year average growth has now been in the 7.5-10% range in the past three quarters, far better than the 3.7% CAGR growth in the five years ended FY20. * There was a significant miss of ~30% on the EBITDA front v/s our expectation due to increasing material cost ...
Buy Emami Ltd For Target Rs. 580 - Motilal Oswal
Buy Emami Ltd For Target Rs. 580 - Motilal Oswal
Source: Motilal Oswal Financial Services
18/06/2021 10:25:40 AM
Emami jumps after raising product prices by 4% to offset cost pressure Emami is currently trading at Rs. 543.75, up by 5.40 points or 1.00% from its previous closing of Rs. 538.35 on the BSE. The scrip opened at Rs. 540.00 and has touched a high and low of Rs. 546.75 and Rs. 538.30 respectively. So far 1829 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 566.70 on 04-Jun-2021 and a 52 week low of Rs. 184.80 on 12-Jun-2020. Last one week high and low of the scrip stood at Rs. 566.70...
Emami jumps after raising product prices by 4% to offset cost pressure
Emami jumps after raising product prices by 4% to offset cost pressure
Source: Accord Fintech
7/06/2021 11:38:31 AM
Buy Emami Ltd For Target Rs.603 - Yes Securities Re‐rating to continue with improved growth trends Result Highlights * Revenue growth – 37% growth in consolidated sales with 44% value and 39% volume growth in domestic business, 28% growth in international business and 3% decline in institutional business with fastest growth in healthcare (67%), Kesh King (45%) and pain management (38%). * Margins – Gross margins down 250bps to 62.7% due to commodity inflation especially in edible oils but EBITDA margins up 380bps to 22....
Buy Emami Ltd For Target Rs.603 - Yes Securities
Buy Emami Ltd For Target Rs.603 - Yes Securities
Source: Yes Securities Ltd
26/05/2021 9:23:53 AM
Key News - Thermax Ltd, AstraZeneca Pharma India Ltd, Godawari Power and Ispat Ltd, Emami Ltd, Bajaj Electricals Ltd, Infosys Ltd by ARETE Securities Key News Thermax March-quarter net jumps nearly three-fold to Rs 107 crore Energy solutions firm Thermax said its consolidated net profit jumped nearly three-fold to Rs 107.35 crore for the March quarter, mainly on the back of higher revenues. The consolidated net profit of the company was Rs 39.03 crore in the quarter ended March 31, 2020, it said in a BSE filing. Total income rose to Rs 1,610.34 crore in the quarter from Rs 1,353.66 crore earlier. For the full fiscal 2020-21, consolid...
Key News - Thermax Ltd, AstraZeneca Pharma India Ltd, Godawari Power and Ispat Ltd, Emami Ltd, Bajaj Electricals Ltd, Infosys Ltd by ARETE Securities
Key News - Thermax Ltd, AstraZeneca Pharma India Ltd, Godawari Power and Ispat Ltd, Emami Ltd, Bajaj Electricals Ltd, Infosys Ltd by ARETE Securities
Source: ARETE Securities Ltd
26/05/2021 9:06:48 AM
Emami Ltd - 4QFY21 Result Update by Mr. Amarjeet Maurya, Angel Broking Below are Views On Emami -4QFY21 Result Update by Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd During the 4QFY21, Emami Ltd (EL) reported revenue of ~Rs731cr (up ~37% YoY) due to healthy growth across the product portfolio. During the quarter, Domestic Business Net Sales grew by 44% & International Business Net Sales grew by 28%. On the EBITDA front, the company has reported Rs163cr and EBITDA margin at 22.3% (up by 378bps yoy). EBITDA margi...
Emami Ltd - 4QFY21 Result Update by Mr. Amarjeet Maurya, Angel Broking
Emami Ltd - 4QFY21 Result Update by Mr. Amarjeet Maurya, Angel Broking
Source: Angel Broking Ltd
25/05/2021 3:46:56 PM
Buy Emami Limited For Target Rs.553 - HDFC Securities Our Take: Emami Limited is one of the leading and fastest growing personal and healthcare businesses in India, with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Mentho Plus Balm, Fast Relief and Kesh King. Emami has a portfolio of over 300+ products based on ayurvedic formulations and has created a growing presence in more than 60 countries with a focused and customized product portfolio. Emami group has a presence across 12 sect...
Buy Emami Limited For Target Rs.553 - HDFC Securities
Buy Emami Limited For Target Rs.553 - HDFC Securities
Source: HDFC Securities Ltd
18/03/2021 11:32:25 AM
Update On Emami Ltd By Yes Securities 3Q investor call takeaways Strong momentum continues across segments and channels, margins reach record levels * Our view – As expected, growth momentum has continued for Emami with muted growth over the past couple of years forming a favorable base, most brand re‐ launches now delivering good results, aggression on new launches contributing, COVID tailwinds also helping and margins reaching new highs. As valuations are still undemanding compared to peers at about 30x FY23 earnin...
Update On Emami Ltd By Yes Securities
Update On Emami Ltd By Yes Securities
Source: Yes Securities Ltd
28/01/2021 11:50:09 AM